| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/18/1993 | WO1993002654A2 A method of inducing hemoglobin synthesis in red blood cells and uses therefor |
| 02/18/1993 | CA2114950A1 Treatment of cell populations |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | EP0453554A4 Chimeric mouse human antibodies with specificity to hiv antigens |
| 02/17/1993 | CN1069124A Antibodies and method for their use |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187090 For tumor diagnosis |
| 02/16/1993 | US5187086 Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten |
| 02/16/1993 | US5187080 For inducing immune response in chickens |
| 02/16/1993 | US5187067 Immunological determination of free human protein S and C4bp-protein S complex |
| 02/16/1993 | US5187064 Monoclonal antibodies and methods for fungal pathogen detection |
| 02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
| 02/10/1993 | WO1993003365A1 Immunoassay, monoclonal antibody and hybridoma |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/10/1993 | CA2075611A1 Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody, and detection systems |
| 02/09/1993 | US5185438 Genetic engineering |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185430 Protein isolated from surface of mammalian or fish cells |
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185250 Human γ, δT cell antigen receptor polypeptides and nucleic acids |
| 02/09/1993 | US5185142 Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/04/1993 | WO1993002358A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | WO1993002198A1 Recombinant secretable fusion proteins |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002106A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | WO1993002105A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | WO1993002098A1 Isolation of charged particles from fluids |
| 02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
| 02/04/1993 | WO1993001835A1 Stabilized human monoclonal antibody preparation |
| 02/04/1993 | WO1993001834A1 Synergistic antibody composition |
| 02/04/1993 | WO1993001827A1 Osteoclast growth regulatory factor |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4222416A1 Monoclonal antibody specific for prostatic acid phosphatase - shows very little cross-reactivity with phosphatase(s) from platelets, erythrocytes or leukocytes, for prostatic cancer diagnosis |
| 02/04/1993 | DE4122599A1 Oberflaechen-expressionsvektor zum screenen von antikoerpern A roughness expression vector for antibody screening |
| 02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
| 02/04/1993 | CA2113828A1 Osteoclast growth regulatory factor |
| 02/04/1993 | CA2113801A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | CA2113578A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113202A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/03/1993 | EP0526397A1 Immunological detection method |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525910A1 Non-A, non-B peptide |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525502A1 Method for the preparation of virus-inactivated immunoglobuline solutions |
| 02/03/1993 | EP0525119A1 Antibody conjugates for treatment of neoplastic disease |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/03/1993 | CA2075165A1 Non-a, non-b peptide |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183756 Produced by a hybridoma assigned A.T.C.C.Accession No.HB 9796; which does not bind with other cancer or normal human tissue; useful for diagnosis and evolution of disease |
| 02/02/1993 | US5183755 Anti-human papillomavirus monoclonal antibody, hybridoma producing the same and process for preparing the same |
| 02/02/1993 | US5183745 Adenyl cyclase derivatives and their biological uses |
| 02/02/1993 | US5183739 Hybridoma which produces antibody binds to an epitope on glycohemoglobin comprising epsilon-d-fructosyllysine is useful for diagnosis of diseases |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183657 Antibodies for use in antilymphocyte antibody therapy |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/28/1993 | DE4143214A1 Synergistisch wirkende antikoerperzusammensetzung Synergistic antikoerperzusammensetzung |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524800A1 Adhesive formulations for binding proteins |
| 01/27/1993 | EP0524737A2 Protein s. polypeptides and anti-peptide antibodies that inhibit protein s binding TO C4b binding protein, diagnostic systems and therapeutic methods |
| 01/27/1993 | EP0524639A2 Process for the labelling of substances with technetium or rhenium |
| 01/27/1993 | EP0524584A2 Method for the preparation of high-affinity hapten-specific antibodies and a composition for the detection of haptens |
| 01/27/1993 | EP0524583A1 Procedure and means for the turbidimetric or nephelometric determination of analyses |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/27/1993 | CA2074590A1 Process for the production of high affinity anti-hapten antibodies and composition for the determination of haptens |
| 01/27/1993 | CA2074547A1 Activator gene for macrolide biosynthesis |
| 01/26/1993 | US5182368 Lymphokines, antibodies |
| 01/26/1993 | US5182364 Polypeptide analogs of apolipoprotein E |
| 01/26/1993 | US5182192 Diagnosis of adenocarcinoma |
| 01/24/1993 | CA2074345A1 Method and agent for the turbidimetric or nephelometric determination of analytes |
| 01/21/1993 | WO1993001316A1 Differentiation of htlv-i and htlv-ii using synthetic peptides |
| 01/21/1993 | WO1993001314A1 DNAs ENCODING PROTEINS ACTIVE IN LYMPHOCYTE-MEDIATED CYTOTOXICITY |
| 01/21/1993 | WO1993001309A1 Assay methods and compositions for detecting serum proteases, particularly activated protein c |
| 01/21/1993 | WO1993001303A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001302A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001296A1 Antibody production in vaccinia virus infected cells |